Cisplatin-Induced Tingling Sensation Timeline
Cisplatin-induced peripheral neuropathy typically develops after prolonged therapy (4-7 months), though neurologic symptoms including tingling can occur after a single dose, and symptoms may begin 3-8 weeks (21-56 days) after the last dose of cisplatin 1.
Timing of Symptom Onset
The FDA drug label clearly states that cisplatin neuropathies "usually occur after prolonged therapy (4 to 7 months); however, neurologic symptoms have been reported to occur after a single dose" 1. Critically, symptoms of neuropathy may begin 3 to 8 weeks after the last dose of cisplatin, demonstrating a delayed onset pattern 1.
Key Clinical Patterns:
- During treatment: Symptoms typically appear during the first 2 months of active treatment 2
- Post-treatment: A "coasting phenomenon" occurs where neuropathy can worsen for 2-3 months after cessation of therapy before improvement begins 3
- Single dose: While rare, neurologic symptoms have been documented even after a single cisplatin dose 1
Clinical Presentation
The sensory neuropathy manifests primarily as:
- Numbness and tingling (appear earlier and are more prominent than pain) 3
- Stocking-glove distribution starting distally in fingers and toes 3
- Symptoms progress proximally as the condition worsens
Critical Management Points
Cisplatin therapy should be discontinued when the first symptoms are observed 1. However, clinicians must recognize that neuropathy may progress further even after stopping treatment, and preliminary evidence suggests peripheral neuropathy may be irreversible in some patients 1.
Dose-Dependent Risk:
A prospective study demonstrated that 47% of patients developed mild or moderate neuropathy at 2 weeks after treatment, which continued to deteriorate until approximately 3 months post-chemotherapy, ultimately affecting 71% with mild-moderate neuropathy and 9% with severe neuropathy 4. The only factor correlated with severity was cumulative cisplatin dose 4.
Common Pitfalls
- Delayed recognition: Don't wait for severe symptoms—tingling and numbness are early warning signs requiring immediate assessment 3
- Underestimating post-treatment worsening: Inform patients that symptoms may worsen for 2-3 months after stopping cisplatin before improvement begins 3
- Assuming reversibility: Peripheral neuropathy may be irreversible in some patients despite treatment discontinuation 1
The 2020 ASCO guidelines emphasize that clinicians should assess the appropriateness of dose delaying, dose reduction, or stopping chemotherapy in patients who develop intolerable neuropathy and/or functional nerve impairment 3.